Veterinary Medicine Information website

FIXR Parvo Lepto

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
Download as PDF

Product identification

Medicine name:
FIXR Parvo Lepto
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
    0.02
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
    0.03
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
    0.02
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
    0.02
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
    0.03
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
    0.03
    Antibody microagglutination-lytic reaction
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • carton box 1 × 20 ml glass vials hydrolytic class II
  • PVC box with cap with 10 holes 10 × 10 ml glass vials of hydrolytic class I
  • carton box 1 × 50 ml glass vials hydrolytic class II
  • carton box 1 × 100 ml glass vials hydrolytic class II
  • carton box 1 × 10 ml glass vials hydrolytic class I

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Similar biological application (Article 13(4) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kernfarm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 125629
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0335/001
Concerned member states:
  • Belgium

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
Download